Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

a Randomised, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects

Inclusion Criteria:

• Age between 19 and 70 years
• Overweight (25 kg/m2 ≤ body mass index (BMI) < 30 kg/m2)

Exclusion Criteria:

• Pregnancy or breast-feeding
• Unstable body weight (body weight change > 10% within 3 months before screening)